IL17A and rheumatoid arthritis: Treatment with rhIL-25 significantly reduced the expression of IL-17A in CD4+ T cells of RA patients, as determined using ELISA and real-time PCR (Fig. 3A,D), but IL-17A expression in HCs was not inhibited by treatment with rhIL-25.